Global Seasonal Influenza Vaccines Market Research Report 2023

Global Seasonal Influenza Vaccines Market Research Report 2023

Table of Contents
1 Seasonal Influenza Vaccines Market Overview
1.1 Product Overview and Scope of Seasonal Influenza Vaccines
1.2 Seasonal Influenza Vaccines Segment by Type
1.2.1 Global Seasonal Influenza Vaccines Market Value Comparison by Type (2023-2029)
1.2.2 Type A (H1N1)
1.2.3 Type A (H3N2)
1.2.4 Type B
1.3 Seasonal Influenza Vaccines Segment by Application
1.3.1 Global Seasonal Influenza Vaccines Market Value by Application: (2023-2029)
1.3.2 Pediatrics
1.3.3 Adolescence
1.3.4 Adults
1.3.5 Elderly
1.4 Global Seasonal Influenza Vaccines Market Size Estimates and Forecasts
1.4.1 Global Seasonal Influenza Vaccines Revenue 2018-2029
1.4.2 Global Seasonal Influenza Vaccines Sales 2018-2029
1.4.3 Global Seasonal Influenza Vaccines Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Seasonal Influenza Vaccines Market Competition by Manufacturers
2.1 Global Seasonal Influenza Vaccines Sales Market Share by Manufacturers (2018-2023)
2.2 Global Seasonal Influenza Vaccines Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Seasonal Influenza Vaccines Average Price by Manufacturers (2018-2023)
2.4 Global Seasonal Influenza Vaccines Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Seasonal Influenza Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Seasonal Influenza Vaccines, Product Type & Application
2.7 Seasonal Influenza Vaccines Market Competitive Situation and Trends
2.7.1 Seasonal Influenza Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Seasonal Influenza Vaccines Players Market Share by Revenue
2.7.3 Global Seasonal Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Seasonal Influenza Vaccines Retrospective Market Scenario by Region
3.1 Global Seasonal Influenza Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Seasonal Influenza Vaccines Global Seasonal Influenza Vaccines Sales by Region: 2018-2029
3.2.1 Global Seasonal Influenza Vaccines Sales by Region: 2018-2023
3.2.2 Global Seasonal Influenza Vaccines Sales by Region: 2024-2029
3.3 Global Seasonal Influenza Vaccines Global Seasonal Influenza Vaccines Revenue by Region: 2018-2029
3.3.1 Global Seasonal Influenza Vaccines Revenue by Region: 2018-2023
3.3.2 Global Seasonal Influenza Vaccines Revenue by Region: 2024-2029
3.4 North America Seasonal Influenza Vaccines Market Facts & Figures by Country
3.4.1 North America Seasonal Influenza Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Seasonal Influenza Vaccines Sales by Country (2018-2029)
3.4.3 North America Seasonal Influenza Vaccines Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Seasonal Influenza Vaccines Market Facts & Figures by Country
3.5.1 Europe Seasonal Influenza Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Seasonal Influenza Vaccines Sales by Country (2018-2029)
3.5.3 Europe Seasonal Influenza Vaccines Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Seasonal Influenza Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Seasonal Influenza Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Seasonal Influenza Vaccines Sales by Country (2018-2029)
3.6.3 Asia Pacific Seasonal Influenza Vaccines Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Seasonal Influenza Vaccines Market Facts & Figures by Country
3.7.1 Latin America Seasonal Influenza Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Seasonal Influenza Vaccines Sales by Country (2018-2029)
3.7.3 Latin America Seasonal Influenza Vaccines Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Seasonal Influenza Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Seasonal Influenza Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Seasonal Influenza Vaccines Sales by Country (2018-2029)
3.8.3 Middle East and Africa Seasonal Influenza Vaccines Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Seasonal Influenza Vaccines Sales by Type (2018-2029)
4.1.1 Global Seasonal Influenza Vaccines Sales by Type (2018-2023)
4.1.2 Global Seasonal Influenza Vaccines Sales by Type (2024-2029)
4.1.3 Global Seasonal Influenza Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Seasonal Influenza Vaccines Revenue by Type (2018-2029)
4.2.1 Global Seasonal Influenza Vaccines Revenue by Type (2018-2023)
4.2.2 Global Seasonal Influenza Vaccines Revenue by Type (2024-2029)
4.2.3 Global Seasonal Influenza Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Seasonal Influenza Vaccines Price by Type (2018-2029)
5 Segment by Application
5.1 Global Seasonal Influenza Vaccines Sales by Application (2018-2029)
5.1.1 Global Seasonal Influenza Vaccines Sales by Application (2018-2023)
5.1.2 Global Seasonal Influenza Vaccines Sales by Application (2024-2029)
5.1.3 Global Seasonal Influenza Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Seasonal Influenza Vaccines Revenue by Application (2018-2029)
5.2.1 Global Seasonal Influenza Vaccines Revenue by Application (2018-2023)
5.2.2 Global Seasonal Influenza Vaccines Revenue by Application (2024-2029)
5.2.3 Global Seasonal Influenza Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Seasonal Influenza Vaccines Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GlaxoSmithKline plc
6.1.1 GlaxoSmithKline plc Corporation Information
6.1.2 GlaxoSmithKline plc Description and Business Overview
6.1.3 GlaxoSmithKline plc Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GlaxoSmithKline plc Seasonal Influenza Vaccines Product Portfolio
6.1.5 GlaxoSmithKline plc Recent Developments/Updates
6.2 Sinovac Biotech Ltd
6.2.1 Sinovac Biotech Ltd Corporation Information
6.2.2 Sinovac Biotech Ltd Description and Business Overview
6.2.3 Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Portfolio
6.2.5 Sinovac Biotech Ltd Recent Developments/Updates
6.3 Changsheng Bio-Technology
6.3.1 Changsheng Bio-Technology Corporation Information
6.3.2 Changsheng Bio-Technology Description and Business Overview
6.3.3 Changsheng Bio-Technology Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Changsheng Bio-Technology Seasonal Influenza Vaccines Product Portfolio
6.3.5 Changsheng Bio-Technology Recent Developments/Updates
6.4 Ccbio SA
6.4.1 Ccbio SA Corporation Information
6.4.2 Ccbio SA Description and Business Overview
6.4.3 Ccbio SA Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ccbio SA Seasonal Influenza Vaccines Product Portfolio
6.4.5 Ccbio SA Recent Developments/Updates
6.5 Aleph Biomedical
6.5.1 Aleph Biomedical Corporation Information
6.5.2 Aleph Biomedical Description and Business Overview
6.5.3 Aleph Biomedical Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Aleph Biomedical Seasonal Influenza Vaccines Product Portfolio
6.5.5 Aleph Biomedical Recent Developments/Updates
6.6 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Sanofi Seasonal Influenza Vaccines Product Portfolio
6.6.5 Sanofi Recent Developments/Updates
6.7 Jiangsu Simcere Vaxtec Bio-pharmaceutical
6.6.1 Jiangsu Simcere Vaxtec Bio-pharmaceutical Corporation Information
6.6.2 Jiangsu Simcere Vaxtec Bio-pharmaceutical Description and Business Overview
6.6.3 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Portfolio
6.7.5 Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments/Updates
6.8 Dalian Hissen Bio-pharm
6.8.1 Dalian Hissen Bio-pharm Corporation Information
6.8.2 Dalian Hissen Bio-pharm Description and Business Overview
6.8.3 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Portfolio
6.8.5 Dalian Hissen Bio-pharm Recent Developments/Updates
6.9 Abbott Laboratories
6.9.1 Abbott Laboratories Corporation Information
6.9.2 Abbott Laboratories Description and Business Overview
6.9.3 Abbott Laboratories Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Abbott Laboratories Seasonal Influenza Vaccines Product Portfolio
6.9.5 Abbott Laboratories Recent Developments/Updates
6.10 Novartis International AG
6.10.1 Novartis International AG Corporation Information
6.10.2 Novartis International AG Description and Business Overview
6.10.3 Novartis International AG Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Novartis International AG Seasonal Influenza Vaccines Product Portfolio
6.10.5 Novartis International AG Recent Developments/Updates
6.11 AstraZeneca
6.11.1 AstraZeneca Corporation Information
6.11.2 AstraZeneca Seasonal Influenza Vaccines Description and Business Overview
6.11.3 AstraZeneca Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.11.4 AstraZeneca Seasonal Influenza Vaccines Product Portfolio
6.11.5 AstraZeneca Recent Developments/Updates
6.12 EMERGEX VACCINES
6.12.1 EMERGEX VACCINES Corporation Information
6.12.2 EMERGEX VACCINES Seasonal Influenza Vaccines Description and Business Overview
6.12.3 EMERGEX VACCINES Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.12.4 EMERGEX VACCINES Seasonal Influenza Vaccines Product Portfolio
6.12.5 EMERGEX VACCINES Recent Developments/Updates
6.13 SINOVAC
6.13.1 SINOVAC Corporation Information
6.13.2 SINOVAC Seasonal Influenza Vaccines Description and Business Overview
6.13.3 SINOVAC Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.13.4 SINOVAC Seasonal Influenza Vaccines Product Portfolio
6.13.5 SINOVAC Recent Developments/Updates
6.14 Merck & Co., Inc.
6.14.1 Merck & Co., Inc. Corporation Information
6.14.2 Merck & Co., Inc. Seasonal Influenza Vaccines Description and Business Overview
6.14.3 Merck & Co., Inc. Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Merck & Co., Inc. Seasonal Influenza Vaccines Product Portfolio
6.14.5 Merck & Co., Inc. Recent Developments/Updates
6.15 Pfizer Inc
6.15.1 Pfizer Inc Corporation Information
6.15.2 Pfizer Inc Seasonal Influenza Vaccines Description and Business Overview
6.15.3 Pfizer Inc Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Pfizer Inc Seasonal Influenza Vaccines Product Portfolio
6.15.5 Pfizer Inc Recent Developments/Updates
6.16 Viatris Inc.
6.16.1 Viatris Inc. Corporation Information
6.16.2 Viatris Inc. Seasonal Influenza Vaccines Description and Business Overview
6.16.3 Viatris Inc. Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Viatris Inc. Seasonal Influenza Vaccines Product Portfolio
6.16.5 Viatris Inc. Recent Developments/Updates
6.17 Vaxess Technologies Inc
6.17.1 Vaxess Technologies Inc Corporation Information
6.17.2 Vaxess Technologies Inc Seasonal Influenza Vaccines Description and Business Overview
6.17.3 Vaxess Technologies Inc Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Vaxess Technologies Inc Seasonal Influenza Vaccines Product Portfolio
6.17.5 Vaxess Technologies Inc Recent Developments/Updates
6.18 OSIVAX
6.18.1 OSIVAX Corporation Information
6.18.2 OSIVAX Seasonal Influenza Vaccines Description and Business Overview
6.18.3 OSIVAX Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.18.4 OSIVAX Seasonal Influenza Vaccines Product Portfolio
6.18.5 OSIVAX Recent Developments/Updates
6.19 CSL Limited
6.19.1 CSL Limited Corporation Information
6.19.2 CSL Limited Seasonal Influenza Vaccines Description and Business Overview
6.19.3 CSL Limited Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.19.4 CSL Limited Seasonal Influenza Vaccines Product Portfolio
6.19.5 CSL Limited Recent Developments/Updates
6.20 EMERGENT
6.20.1 EMERGENT Corporation Information
6.20.2 EMERGENT Seasonal Influenza Vaccines Description and Business Overview
6.20.3 EMERGENT Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.20.4 EMERGENT Seasonal Influenza Vaccines Product Portfolio
6.20.5 EMERGENT Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Seasonal Influenza Vaccines Industry Chain Analysis
7.2 Seasonal Influenza Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Seasonal Influenza Vaccines Production Mode & Process
7.4 Seasonal Influenza Vaccines Sales and Marketing
7.4.1 Seasonal Influenza Vaccines Sales Channels
7.4.2 Seasonal Influenza Vaccines Distributors
7.5 Seasonal Influenza Vaccines Customers
8 Seasonal Influenza Vaccines Market Dynamics
8.1 Seasonal Influenza Vaccines Industry Trends
8.2 Seasonal Influenza Vaccines Market Drivers
8.3 Seasonal Influenza Vaccines Market Challenges
8.4 Seasonal Influenza Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Seasonal Influenza Vaccines Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Seasonal Influenza Vaccines Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Seasonal Influenza Vaccines Market Competitive Situation by Manufacturers in 2022
Table 4. Global Seasonal Influenza Vaccines Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Seasonal Influenza Vaccines Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Seasonal Influenza Vaccines Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Seasonal Influenza Vaccines Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Seasonal Influenza Vaccines Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Seasonal Influenza Vaccines, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Seasonal Influenza Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Seasonal Influenza Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Seasonal Influenza Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Seasonal Influenza Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Seasonal Influenza Vaccines as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Seasonal Influenza Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Seasonal Influenza Vaccines Sales by Region (2018-2023) & (K Units)
Table 18. Global Seasonal Influenza Vaccines Sales Market Share by Region (2018-2023)
Table 19. Global Seasonal Influenza Vaccines Sales by Region (2024-2029) & (K Units)
Table 20. Global Seasonal Influenza Vaccines Sales Market Share by Region (2024-2029)
Table 21. Global Seasonal Influenza Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2018-2023)
Table 23. Global Seasonal Influenza Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2024-2029)
Table 25. North America Seasonal Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Seasonal Influenza Vaccines Sales by Country (2018-2023) & (K Units)
Table 27. North America Seasonal Influenza Vaccines Sales by Country (2024-2029) & (K Units)
Table 28. North America Seasonal Influenza Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Seasonal Influenza Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Seasonal Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Seasonal Influenza Vaccines Sales by Country (2018-2023) & (K Units)
Table 32. Europe Seasonal Influenza Vaccines Sales by Country (2024-2029) & (K Units)
Table 33. Europe Seasonal Influenza Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Seasonal Influenza Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Seasonal Influenza Vaccines Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Seasonal Influenza Vaccines Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Seasonal Influenza Vaccines Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Seasonal Influenza Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Seasonal Influenza Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Seasonal Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Seasonal Influenza Vaccines Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Seasonal Influenza Vaccines Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Seasonal Influenza Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Seasonal Influenza Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Seasonal Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Seasonal Influenza Vaccines Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Seasonal Influenza Vaccines Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Seasonal Influenza Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Seasonal Influenza Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Seasonal Influenza Vaccines Sales (K Units) by Type (2018-2023)
Table 51. Global Seasonal Influenza Vaccines Sales (K Units) by Type (2024-2029)
Table 52. Global Seasonal Influenza Vaccines Sales Market Share by Type (2018-2023)
Table 53. Global Seasonal Influenza Vaccines Sales Market Share by Type (2024-2029)
Table 54. Global Seasonal Influenza Vaccines Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Seasonal Influenza Vaccines Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Seasonal Influenza Vaccines Revenue Market Share by Type (2018-2023)
Table 57. Global Seasonal Influenza Vaccines Revenue Market Share by Type (2024-2029)
Table 58. Global Seasonal Influenza Vaccines Price (USD/Unit) by Type (2018-2023)
Table 59. Global Seasonal Influenza Vaccines Price (USD/Unit) by Type (2024-2029)
Table 60. Global Seasonal Influenza Vaccines Sales (K Units) by Application (2018-2023)
Table 61. Global Seasonal Influenza Vaccines Sales (K Units) by Application (2024-2029)
Table 62. Global Seasonal Influenza Vaccines Sales Market Share by Application (2018-2023)
Table 63. Global Seasonal Influenza Vaccines Sales Market Share by Application (2024-2029)
Table 64. Global Seasonal Influenza Vaccines Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Seasonal Influenza Vaccines Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Seasonal Influenza Vaccines Revenue Market Share by Application (2018-2023)
Table 67. Global Seasonal Influenza Vaccines Revenue Market Share by Application (2024-2029)
Table 68. Global Seasonal Influenza Vaccines Price (USD/Unit) by Application (2018-2023)
Table 69. Global Seasonal Influenza Vaccines Price (USD/Unit) by Application (2024-2029)
Table 70. GlaxoSmithKline plc Corporation Information
Table 71. GlaxoSmithKline plc Description and Business Overview
Table 72. GlaxoSmithKline plc Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. GlaxoSmithKline plc Seasonal Influenza Vaccines Product
Table 74. GlaxoSmithKline plc Recent Developments/Updates
Table 75. Sinovac Biotech Ltd Corporation Information
Table 76. Sinovac Biotech Ltd Description and Business Overview
Table 77. Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Sinovac Biotech Ltd Seasonal Influenza Vaccines Product
Table 79. Sinovac Biotech Ltd Recent Developments/Updates
Table 80. Changsheng Bio-Technology Corporation Information
Table 81. Changsheng Bio-Technology Description and Business Overview
Table 82. Changsheng Bio-Technology Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Changsheng Bio-Technology Seasonal Influenza Vaccines Product
Table 84. Changsheng Bio-Technology Recent Developments/Updates
Table 85. Ccbio SA Corporation Information
Table 86. Ccbio SA Description and Business Overview
Table 87. Ccbio SA Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Ccbio SA Seasonal Influenza Vaccines Product
Table 89. Ccbio SA Recent Developments/Updates
Table 90. Aleph Biomedical Corporation Information
Table 91. Aleph Biomedical Description and Business Overview
Table 92. Aleph Biomedical Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Aleph Biomedical Seasonal Influenza Vaccines Product
Table 94. Aleph Biomedical Recent Developments/Updates
Table 95. Sanofi Corporation Information
Table 96. Sanofi Description and Business Overview
Table 97. Sanofi Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Sanofi Seasonal Influenza Vaccines Product
Table 99. Sanofi Recent Developments/Updates
Table 100. Jiangsu Simcere Vaxtec Bio-pharmaceutical Corporation Information
Table 101. Jiangsu Simcere Vaxtec Bio-pharmaceutical Description and Business Overview
Table 102. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product
Table 104. Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments/Updates
Table 105. Dalian Hissen Bio-pharm Corporation Information
Table 106. Dalian Hissen Bio-pharm Description and Business Overview
Table 107. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product
Table 109. Dalian Hissen Bio-pharm Recent Developments/Updates
Table 110. Abbott Laboratories Corporation Information
Table 111. Abbott Laboratories Description and Business Overview
Table 112. Abbott Laboratories Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Abbott Laboratories Seasonal Influenza Vaccines Product
Table 114. Abbott Laboratories Recent Developments/Updates
Table 115. Novartis International AG Corporation Information
Table 116. Novartis International AG Description and Business Overview
Table 117. Novartis International AG Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Novartis International AG Seasonal Influenza Vaccines Product
Table 119. Novartis International AG Recent Developments/Updates
Table 120. AstraZeneca Corporation Information
Table 121. AstraZeneca Description and Business Overview
Table 122. AstraZeneca Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. AstraZeneca Seasonal Influenza Vaccines Product
Table 124. AstraZeneca Recent Developments/Updates
Table 125. EMERGEX VACCINES Corporation Information
Table 126. EMERGEX VACCINES Description and Business Overview
Table 127. EMERGEX VACCINES Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. EMERGEX VACCINES Seasonal Influenza Vaccines Product
Table 129. EMERGEX VACCINES Recent Developments/Updates
Table 130. SINOVAC Corporation Information
Table 131. SINOVAC Description and Business Overview
Table 132. SINOVAC Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. SINOVAC Seasonal Influenza Vaccines Product
Table 134. SINOVAC Recent Developments/Updates
Table 135. Merck & Co., Inc. Corporation Information
Table 136. Merck & Co., Inc. Description and Business Overview
Table 137. Merck & Co., Inc. Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Merck & Co., Inc. Seasonal Influenza Vaccines Product
Table 139. Merck & Co., Inc. Recent Developments/Updates
Table 140. Pfizer Inc Corporation Information
Table 141. Pfizer Inc Description and Business Overview
Table 142. Pfizer Inc Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Pfizer Inc Seasonal Influenza Vaccines Product
Table 144. Pfizer Inc Recent Developments/Updates
Table 145. Viatris Inc. Corporation Information
Table 146. Viatris Inc. Description and Business Overview
Table 147. Viatris Inc. Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. Viatris Inc. Seasonal Influenza Vaccines Product
Table 149. Viatris Inc. Recent Developments/Updates
Table 150. Vaxess Technologies Inc Corporation Information
Table 151. Vaxess Technologies Inc Description and Business Overview
Table 152. Vaxess Technologies Inc Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 153. Vaxess Technologies Inc Seasonal Influenza Vaccines Product
Table 154. Vaxess Technologies Inc Recent Developments/Updates
Table 155. OSIVAX Corporation Information
Table 156. OSIVAX Description and Business Overview
Table 157. OSIVAX Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 158. OSIVAX Seasonal Influenza Vaccines Product
Table 159. OSIVAX Recent Developments/Updates
Table 160. CSL Limited Corporation Information
Table 161. CSL Limited Description and Business Overview
Table 162. CSL Limited Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 163. CSL Limited Seasonal Influenza Vaccines Product
Table 164. CSL Limited Recent Developments/Updates
Table 165. EMERGENT Corporation Information
Table 166. EMERGENT Description and Business Overview
Table 167. EMERGENT Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 168. EMERGENT Seasonal Influenza Vaccines Product
Table 169. EMERGENT Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Seasonal Influenza Vaccines Distributors List
Table 173. Seasonal Influenza Vaccines Customers List
Table 174. Seasonal Influenza Vaccines Market Trends
Table 175. Seasonal Influenza Vaccines Market Drivers
Table 176. Seasonal Influenza Vaccines Market Challenges
Table 177. Seasonal Influenza Vaccines Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Seasonal Influenza Vaccines
Figure 2. Global Seasonal Influenza Vaccines Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Seasonal Influenza Vaccines Market Share by Type in 2022 & 2029
Figure 4. Type A (H1N1) Product Picture
Figure 5. Type A (H3N2) Product Picture
Figure 6. Type B Product Picture
Figure 7. Global Seasonal Influenza Vaccines Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Seasonal Influenza Vaccines Market Share by Application in 2022 & 2029
Figure 9. Pediatrics
Figure 10. Adolescence
Figure 11. Adults
Figure 12. Elderly
Figure 13. Global Seasonal Influenza Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Seasonal Influenza Vaccines Market Size (2018-2029) & (US$ Million)
Figure 15. Global Seasonal Influenza Vaccines Sales (2018-2029) & (K Units)
Figure 16. Global Seasonal Influenza Vaccines Average Price (USD/Unit) & (2018-2029)
Figure 17. Seasonal Influenza Vaccines Report Years Considered
Figure 18. Seasonal Influenza Vaccines Sales Share by Manufacturers in 2022
Figure 19. Global Seasonal Influenza Vaccines Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Seasonal Influenza Vaccines Players: Market Share by Revenue in 2022
Figure 21.

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs